These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24646641)

  • 1. Varenicline-assisted smoking cessation decreases oxidative stress and restores endothelial function.
    Kato T; Umeda A; Miyagawa K; Takeda H; Adachi T; Toyoda S; Taguchi I; Inoue T; Node K
    Hypertens Res; 2014 Jul; 37(7):655-8. PubMed ID: 24646641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
    Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K
    Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does smoking cessation with varenicline worsen vascular endothelial function?
    Umeda A; Kato T; Yamane T; Yano H; Ieiri T; Miyagawa K; Takeda H; Okada Y
    BMJ Open; 2013 Jun; 3(6):. PubMed ID: 23794597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers.
    Loughead J; Ray R; Wileyto EP; Ruparel K; Sanborn P; Siegel S; Gur RC; Lerman C
    Biol Psychiatry; 2010 Apr; 67(8):715-21. PubMed ID: 20207347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.
    Lam S; Patel PN
    Cardiol Rev; 2007; 15(3):154-61. PubMed ID: 17438382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term passive smoking causes endothelial dysfunction via oxidative stress in nonsmokers.
    Kato T; Inoue T; Morooka T; Yoshimoto N; Node K
    Can J Physiol Pharmacol; 2006 May; 84(5):523-9. PubMed ID: 16902597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. γ-Tocopherol-rich supplementation additively improves vascular endothelial function during smoking cessation.
    Mah E; Pei R; Guo Y; Ballard KD; Barker T; Rogers VE; Parker BA; Taylor AW; Traber MG; Volek JS; Bruno RS
    Free Radic Biol Med; 2013 Dec; 65():1291-1299. PubMed ID: 24075893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial.
    Johnson HM; Gossett LK; Piper ME; Aeschlimann SE; Korcarz CE; Baker TB; Fiore MC; Stein JH
    J Am Coll Cardiol; 2010 May; 55(18):1988-95. PubMed ID: 20236788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
    Rollema H; Chambers LK; Coe JW; Glowa J; Hurst RS; Lebel LA; Lu Y; Mansbach RS; Mather RJ; Rovetti CC; Sands SB; Schaeffer E; Schulz DW; Tingley FD; Williams KE
    Neuropharmacology; 2007 Mar; 52(3):985-94. PubMed ID: 17157884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varenicline and its role in smoking cessation.
    Kapoor S
    Prev Cardiol; 2008; 11(3):168-71. PubMed ID: 18607153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observational study of safety and efficacy of varenicline for smoking cessation among Filipino smokers.
    Park PW; Casiano EM; Escoto L; Claveria AM
    Curr Med Res Opin; 2011 Oct; 27(10):1869-75. PubMed ID: 21838412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.
    Coe JW; Brooks PR; Vetelino MG; Wirtz MC; Arnold EP; Huang J; Sands SB; Davis TI; Lebel LA; Fox CB; Shrikhande A; Heym JH; Schaeffer E; Rollema H; Lu Y; Mansbach RS; Chambers LK; Rovetti CC; Schulz DW; Tingley FD; O'Neill BT
    J Med Chem; 2005 May; 48(10):3474-7. PubMed ID: 15887955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single- and multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy Japanese adult smokers.
    Kikkawa H; Maruyama N; Fujimoto Y; Hasunuma T
    J Clin Pharmacol; 2011 Apr; 51(4):527-37. PubMed ID: 20551220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of varenicline as an aid to smoking cessation: results of an inter-European observational study.
    Boudrez H; Gratziou C; Messig M; Metcalfe M
    Curr Med Res Opin; 2011 Apr; 27(4):769-75. PubMed ID: 21294601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive effect of varenicline on impairment of endothelial function in cerebral vessels induced by acute smoking in rats.
    Iida M; Iida H; Takenaka M; Tanabe K; Iwata K
    J Anesth; 2012 Dec; 26(6):928-31. PubMed ID: 22744869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness and safety of varenicline for smoking cessation].
    Christalla P; Dewenter M; El-Armouche A
    Dtsch Med Wochenschr; 2012 May; 137(18):940-4. PubMed ID: 22492478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors.
    Mihalak KB; Carroll FI; Luetje CW
    Mol Pharmacol; 2006 Sep; 70(3):801-5. PubMed ID: 16766716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varenicline in the management of smoking cessation: a single technology appraisal.
    Hind D; Tappenden P; Peters J; Kenjegalieva K
    Health Technol Assess; 2009 Sep; 13 Suppl 2():9-13. PubMed ID: 19804684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy smokers.
    Faessel HM; Gibbs MA; Clark DJ; Rohrbacher K; Stolar M; Burstein AH
    J Clin Pharmacol; 2006 Dec; 46(12):1439-48. PubMed ID: 17101743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.